Intervention Review

Addition of intravenous beta2-agonists to inhaled beta2-agonists for acute asthma

  1. Andrew H Travers1,*,
  2. Stephen J Milan2,
  3. Arthur P Jones3,
  4. Carlos A Camargo Jr4,
  5. Brian H Rowe5,6

Editorial Group: Cochrane Airways Group

Published Online: 12 DEC 2012

Assessed as up-to-date: 28 SEP 2012

DOI: 10.1002/14651858.CD010179

How to Cite

Travers AH, Milan SJ, Jones AP, Camargo Jr CA, Rowe BH. Addition of intravenous beta2-agonists to inhaled beta2-agonists for acute asthma. Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD010179. DOI: 10.1002/14651858.CD010179.

Author Information

  1. 1

    Emergency Health Services, Department of Emergency Medicine and Community Health and Epidemiology, Nova Scotia, Canada

  2. 2

    St George's, University of London, Population Health Sciences and Education, London, UK

  3. 3

    c/o Cochrane Airways Group, London, UK

  4. 4

    Massachusetts General Hospital, Department of Emergency Medicine, Boston, Massachusetts, USA

  5. 5

    University of Alberta, Department of Emergency Medicine, Edmonton, Alberta, Canada

  6. 6

    University of Alberta, School of Public Heath, Edmonton, Canada

*Andrew H Travers, Department of Emergency Medicine and Community Health and Epidemiology, Emergency Health Services, Nova Scotia, Canada. Andrew.Travers@gov.ns.ca.

Publication History

  1. Publication Status: New
  2. Published Online: 12 DEC 2012

SEARCH